Advent Proposes $1.02/Share Buyout of Definitive Healthcare — 36% Premium
DH sits 46% above its 52-week low of $0.61.
Summary
Advent International, which already owns 58.54% of Definitive Healthcare, has proposed to acquire all remaining shares for $1.02 per share in cash — a 36% premium to the 60-day VWAP. The non-binding proposal is not subject to financing conditions and is premised on founder Jason Krantz rolling over his equity.
Key Events · M&A and Partnerships · DH
-
Advent Proposes $1.02/Share Buyout
Advent International submitted a non-binding proposal on September 1, 2026 to acquire all outstanding shares of Definitive Healthcare not already owned by Advent and Jason Krantz for $1.02 per share in cash.
-
36% Premium to 60-Day VWAP
The $1.02 offer price represents a 36% premium to the 60-day volume-weighted average trading price of $0.75 per share as of August 31, 2026.
-
No Financing Condition
The proposal is not subject to any financing condition, and Advent states it does not anticipate substantial regulatory hurdles or delays.
-
Founder Rollover Required
The proposal is premised on Executive Chairman and founder Jason Krantz rolling over his Common Stock and Definitive OpCo Units into equity of the surviving company.
Analysis · DH · Technology
Advent International, already the controlling shareholder with 58.54% of Definitive Healthcare, has submitted a non-binding proposal to acquire all remaining shares it does not already own for $1.02 per share in cash. The offer represents a 36% premium to the 60-day VWAP of $0.75 as of August 31, 2026, and is not subject to any financing condition. The proposal is premised on founder and Executive Chairman Jason Krantz rolling over his equity into the surviving company. This is a significant development for a company that received a Nasdaq delisting notice in June 2026 and reported declining revenue in Q2 2026. The proposal provides minority shareholders with an immediate liquidity opportunity at a substantial premium to recent trading levels, though it remains non-binding and subject to Special Committee approval and negotiation of definitive agreements.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 43.9% of the 553 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, DH was trading at $0.89 on NASDAQ in the Technology sector, with a market capitalization of approximately $130.7M. The 52-week trading range was $0.61 to $4.35. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.